Anzeige
Mehr »
Login
Freitag, 14.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Rekordumsatz in Millionenhöhe – diese Aktie steht vor einer Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
843 Leser
Artikel bewerten:
(2)

CBDfx UK: CBDfx Added to FSA's Public List of CBD Products

GUILDFORD, United Kingdom, April 29, 2022 /PRNewswire/ -- Leading CBD products company, CBDfx, today announced that it has been included in the Food Standards Agency's (FSA) list of products that are permitted to stay on the market pending validation of their Novel Foods Application. Only CBD products with credible applications that exhibit a path to validation can legally stay on the UK market. It is an important milestone for the company, putting them on the path to full authorization. The time frames for this are still unclear but with toxicology data due to be submitted in weeks, CBDfx aims to be one of the first natural hemp derived CBD brands to be validated and subsequently authorized.

CBDfx popular CBD gummies are a fun and easy way to add the calming wellness of CBD to your daily routine.

"The inclusion of all our edible products on the FSA's Public List underscores the high standards that CBDfx operates under," stated Carlo Buckley, Managing Director for CBDfx Europe. "We wholeheartedly embrace the move by the FSA to provide a clear regulatory framework under which CBD companies operate" continued Buckley.

CBDfx is one of the UK's most popular CBD brands, with a retail presence across both mass market pharmacy retailers like Superdrug and Boots, and high street, where its market-leading CBD gummies are a top-seller at the likes of Selfridges and Planet Organic.

The company was one of only a handful of CBD companies included in Amazon UK's CBD pilot program and the only US headquartered brand, where it continues to dominate as the #1 CBD brand by market share. CBDfx is also one of only a curated few CBD companies invited to participate in eBay UK's CBD pilot program, where shoppers can enjoy the company's popular CBD gummies, drops, and topicals.

CBDfx products are available in thousands of retail locations across the United Kingdom and via its DTC website, making its products available to an additional 22 countries across Europe.

The company's inclusion on the Public List allows it to continue to offer its wide range of extremely popular CBD products on the UK market while their application moves onto the next step in the FSA validation process.

A novel food is defined by the FSA as any food that had not been consumed by humans in the EU prior to 15 May 1997.

About CBDfx UK: CBDfx UK is a wholly-owned subsidiary of CBDfx, a US-based company founded on providing high quality, organically-sourced hemp-derived cannabidiol (CBD) wellness products to customers in a wide variety of formats; from oil drops to topicals, and gummies to capsules. Founded in California in 2014 with a mission to push quality to the forefront of the CBD industry, CBDfx provides some of the finest, purest, and most effective CBD products in the world. CBDfx products are sold in more than 25,000 points of distribution in 21 countries, and online at www.CBDfx.co.uk.

CBDfx
Carlo Buckley
carlo@cbdfx.co.uk
+44(0)1483 362875

CBDfx company logo

Photo - https://mma.prnewswire.com/media/1807560/CBDfx_Gummies.jpg
Logo - https://mma.prnewswire.com/media/1807559/CBDfx_Logo.jpg

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.